Nef-mediated resistance of human immunodeficiency virus type 1 to antiviral cytotoxic T lymphocytes. 2002

Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
Division of Infectious Diseases and AIDS Institute, UCLA Medical Center, Los Angeles, California 90095, USA. oyang@mednet.ucla.edu

Although Nef has been proposed to effect the escape of human immunodeficiency virus type 1 (HIV-1) from cytotoxic T lymphocytes (CTL) through downmodulation of major histocompatibility complex class I molecules, little direct data have been presented previously to support this hypothesis. By comparing nef-competent and nef-deleted HIV-1 strains in an in vitro coculture system, we demonstrate that the presence of this viral accessory gene leads to impairment of the ability of HIV-1-specific CTL clones to suppress viral replication. Furthermore, inhibition by genetically modified CTL that do not require major histocompatibility complex class I-presented antigen (expressing the CD4 T-cell receptor [TCR] zeta-chain hybrid receptor) is similar for both nef-competent and -deleted strains, indicating that Nef does not impair the effector functions of CTL but acts at the level of TCR triggering. In contrast, we note that another accessory gene, vpr, does not induce resistance of HIV-1 to suppression by CTL clones. We conclude that Nef (and not Vpr) contributes to functional HIV-1 immune evasion and that this effect is mediated by diminished antigen presentation to CTL.

UI MeSH Term Description Entries
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D013601 T-Lymphocytes Lymphocytes responsible for cell-mediated immunity. Two types have been identified - cytotoxic (T-LYMPHOCYTES, CYTOTOXIC) and helper T-lymphocytes (T-LYMPHOCYTES, HELPER-INDUCER). They are formed when lymphocytes circulate through the THYMUS GLAND and differentiate to thymocytes. When exposed to an antigen, they divide rapidly and produce large numbers of new T cells sensitized to that antigen. T Cell,T Lymphocyte,T-Cells,Thymus-Dependent Lymphocytes,Cell, T,Cells, T,Lymphocyte, T,Lymphocyte, Thymus-Dependent,Lymphocytes, T,Lymphocytes, Thymus-Dependent,T Cells,T Lymphocytes,T-Cell,T-Lymphocyte,Thymus Dependent Lymphocytes,Thymus-Dependent Lymphocyte
D013602 T-Lymphocytes, Cytotoxic Immunized T-lymphocytes which can directly destroy appropriate target cells. These cytotoxic lymphocytes may be generated in vitro in mixed lymphocyte cultures (MLC), in vivo during a graft-versus-host (GVH) reaction, or after immunization with an allograft, tumor cell or virally transformed or chemically modified target cell. The lytic phenomenon is sometimes referred to as cell-mediated lympholysis (CML). These CD8-positive cells are distinct from NATURAL KILLER CELLS and NATURAL KILLER T-CELLS. There are two effector phenotypes: TC1 and TC2. Cell-Mediated Lympholytic Cells,Cytotoxic T Cells,Cytotoxic T Lymphocyte,Cytotoxic T-Lymphocytes,TC1 Cell,TC1 Cells,TC2 Cell,TC2 Cells,Cell Mediated Lympholytic Cells,Cell, Cell-Mediated Lympholytic,Cell, TC1,Cell, TC2,Cell-Mediated Lympholytic Cell,Cytotoxic T Cell,Cytotoxic T Lymphocytes,Cytotoxic T-Lymphocyte,Lymphocyte, Cytotoxic T,Lympholytic Cell, Cell-Mediated,Lympholytic Cells, Cell-Mediated,T Cell, Cytotoxic,T Lymphocyte, Cytotoxic,T Lymphocytes, Cytotoxic,T-Lymphocyte, Cytotoxic
D014779 Virus Replication The process of intracellular viral multiplication, consisting of the synthesis of PROTEINS; NUCLEIC ACIDS; and sometimes LIPIDS, and their assembly into a new infectious particle. Viral Replication,Replication, Viral,Replication, Virus,Replications, Viral,Replications, Virus,Viral Replications,Virus Replications
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015658 HIV Infections Includes the spectrum of human immunodeficiency virus infections that range from asymptomatic seropositivity, thru AIDS-related complex (ARC), to acquired immunodeficiency syndrome (AIDS). HTLV-III Infections,HTLV-III-LAV Infections,T-Lymphotropic Virus Type III Infections, Human,HIV Coinfection,Coinfection, HIV,Coinfections, HIV,HIV Coinfections,HIV Infection,HTLV III Infections,HTLV III LAV Infections,HTLV-III Infection,HTLV-III-LAV Infection,Infection, HIV,Infection, HTLV-III,Infection, HTLV-III-LAV,Infections, HIV,Infections, HTLV-III,Infections, HTLV-III-LAV,T Lymphotropic Virus Type III Infections, Human
D015693 Gene Products, nef Products of the retroviral NEF GENE. They play a role as accessory proteins that influence the rate of viral infectivity and the destruction of the host immune system. nef gene products were originally found as factors that trans-suppress viral replication and function as negative regulators of transcription. nef stands for negative factor. nef Gene Products,nef Protein,3'-orf Protein,Gene Product, nef,3' orf Protein,nef Gene Product
D054311 nef Gene Products, Human Immunodeficiency Virus Proteins encoded by the NEF GENES of the HUMAN IMMUNODEFICIENCY VIRUS. nef Protein, Human Immunodeficiency Virus,HIV-3'-orf Protein,nef Protein, HIV,HIV 3' orf Protein,HIV nef Protein

Related Publications

Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
May 2002, Journal of virology,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
August 1999, Journal of virology,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
June 1996, The Journal of experimental medicine,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
November 1998, AIDS research and human retroviruses,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
February 1994, Proceedings of the National Academy of Sciences of the United States of America,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
January 2001, AIDS research and human retroviruses,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
September 1996, Journal of virology,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
April 1995, Virology,
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
September 2000, Molecular medicine (Cambridge, Mass.),
Otto O Yang, and Phuong Thi Nguyen, and Spyros A Kalams, and Tanya Dorfman, and Heinrich G Göttlinger, and Sheila Stewart, and Irvin S Y Chen, and Steven Threlkeld, and Bruce D Walker
March 1994, The Journal of clinical investigation,
Copied contents to your clipboard!